Endogenous regulator of G protein signaling proteins suppress Gαo-dependent, μ-opioid agonist-mediated adenylyl cyclase supersensitization

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 215-222

  Clark, Mary J ^a   Neubig, Richard R ^a   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE ANTAGONIST; PERTUSSIS TOXIN; RGS PROTEIN; TRITIUM;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; ENZYME ACTIVITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEINS; MICE; PERTUSSIS TOXIN; RATS; RECEPTORS, OPIOID, MU; RGS PROTEINS; TUMOR CELLS, CULTURED;

EID: 3042645848     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.064824     Document Type: Article

References (41)

1. Ammer H and Christ TE (2002) Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl supersensitivity. J Neurochem 83:818-827.
2. sα subunit. J Pharmacol Exp Ther 286:855-862.
3. βγ. J Biol Chem 271:21309-21315.
4. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, and Caron MG (2000) μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature (Lond) 408:720-723.
5. 2+ responses in CHO-K1 cells. FEBS Lett 533:67-71.
6. 1 alpha inhibits the calcium dependence of beta-adrenergic stimulated cAMP accumulation in C6 glioma cells. J Biol Chem 268:8980-8989.
7. + channels. Proc Natl Acad Sci USA 95:11727-11732.
8. o. J Biol Chem 278:9418-9425.
9. Debernardi MA, Munshi R, Yoshimura M, Cooper DM, and Brooker G (1993) Predominant expression of type-VI adenylate cyclase in C6-2B rat glioma cells may account for inhibition of cyclic AMP accumulation by calcium. Biochem J 293:325-328.
10. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, and Medzihradsky F (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther 278:1121-1127.
11. Garzón J, Rodriguez-Díaz M, López-Fresdo A, and Sánchez-Blázquez P (2001) RGS9 proteins facilitate acute tolerance to mu-opioid effects. Eur J Neurosci 13:801-811.
12. Gold SJ, Han MH, Herman AE, Ni YG, Pudiak CM, Aghajanian GK, Liu RJ, Potts BW, Mumby SM, and Nestler EJ (2003) Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 17:971-980.
13. qα. Proc Natl Acad Sci USA 94:428-432.
14. Hollinger S and Hepler JR (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharm Rev 54:527-559.
15. Huang LJ, Durick K, Weiner JA, Chun J, and Taylor SS (1997) D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc Natl Acad Sci USA 94:11184-11189.
16. Jeong SW and Ikeda SR (2000) Endogenous regulator of G-protein signaling proteins modify N-type calcium channel modulation in rat sympathetic neurons. J Neurosci 20:4489-4496.
17. i1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem 273:12794-12797.
18. Law PY, Wong YH, and Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430.
19. Lee KO, Akil H, Woods JH, and Traynor JR (1999) Differential binding properties of oripavines at cloned μ- and δ-opioid receptors. Eur J Pharmacol 378:323-330.
20. 2. Biochem J 267:391-398.
21. Milligan G (1988) Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. Biochem J 255:1-13.
22. 1α. J Neurochem 76:1805-1813.
23. Potenza MN, Gold SJ, Roby-Shemkowitz A, Lerner MR, and Nestler EJ (1999) Effects of regulators of G protein-signaling proteins on the functional response of the μ-opioid receptor in a melanophore-bases assay. J Pharmacol Exp Ther 291:482-491.
24. Rubenzik M, Varga E, Stropova D, Roeske WR, and Yamamura HI (2001) Expression of α-transducin in Chinese hamster ovary cells stably transfected with the human δ-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation. Mol Pharmacol 60:1076-1082.
25. Sharma SK, Klee WA, and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
26. Siderovski DP, Strockbine B, and Behe CI (1999) Whither goest the RGS proteins? Crit Rev Biochem Mol Biol 34:215-251.
27. Snow BE, Brothers GM, and Siderovski DP (2002) Molecular cloning of regulators of G-protein signaling family members and characterization of binding specificity of RGS12 PDZ domain. Methods Enzymol 344:740-761.
28. Sunahara RK, Dessauer CW, and Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Ann Rev Pharmacol Toxicol 36:461-480.
29. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, and Nestler EJ (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-110.
30. iα1: stabilization of the transition state for GTP hydrolysis. Cell 89:251-261.
31. 2 in opioid-induced adenylyl cyclase supersensitization. Neuroreport 14:3213-3217.
32. Tso PH and Wong YH (2000b) Gz can mediate the acute actions of μ- and κ-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization. J Pharmacol Exp Ther 295:168-176.
33. 3. Neuroscience Lett 299:25-28.
34. Varga EV, Rubenzik M, Grife V, Sugiyama M, Stropova D, Roeske WR, and Yamamura HI (2002) Involvement of Raf-1 in chronic δ-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur J Pharmacol 451:101-102.
35. Watts VJ (2002) Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7.
36. 2 dopamine receptors. Mol Pharmacol 50:966-976.
37. Watts VJ, Taussig R, Neve RL, and Neve KA (2001) Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Gαs: characterization of Gαs-insensitive mutants of adenylyl cyclase V. Mol Pharmacol 60:1168-1172.
38. 2L dopamine receptors in NS20Y neuroblastoma cells. J Neurosci 18:8692-8699.
39. Yu VC, Eiger S, Duan DS, Lameh J, and Sadée W (1990) Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells. J Neurochem 55:1390-1396.
40. Zachariou V, Georgescue D, Sanchez N, Rahman Z, Di Leone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, et al. (2003) Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 100:13656-13661.
41. Zhong H and Neubig RR (2001) Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther 297:837-845.